Drug Discovery
By
How Will New U.S. Drug Pricing Policies Reshape the Pharmaceutical Ecosystem?
Washington, D.C. — December 29, 2025 — Recent changes in U.S. drug pricing policies are fundamentally reshaping the…
How Did Merck’s 2025 Deals Strengthen Its Pipeline and What Could They Mean for Future Growth?
In 2025, Merck pursued a series of high-impact collaborations, acquisitions, and licensing agreements to expand its portfolio, enhance…
Did Merck’s 2025 Strategies, Deals, and Pipeline Strength Position It for Breakthrough Growth in 2026?
Merck concluded 2025 with a strong performance across its pharmaceuticals, vaccines, and oncology segments, demonstrating resilience, strategic focus,…
Did AstraZeneca’s 2025 Deals Lay the Groundwork for Transformative Growth Across Oncology, Immunology, and Rare Diseases in 2026?
In 2025, AstraZeneca executed a series of strategic collaborations, partnerships, and selective acquisitions designed to strengthen its pipeline,…
Can Amgen’s 2025 Approvals and Launches Strengthen Its Oncology, Cardiovascular, and Bone Health Leadership Into 2026?
Global | January 2026 — Amgen Inc. achieved key milestones in 2025, marked by multiple regulatory approvals, label…
Can GSK’s 2025 Approvals and Launches Strengthen Its Vaccines, Respiratory, and Immunology Leadership Into 2026?
Global | January 2026 — GlaxoSmithKline PLC (GSK) achieved key milestones in 2025, with multiple regulatory approvals, product…
